The study of healthcare-associated infections (HAIs) has seen significant strides, with a pronounced decline in HAI rates at U.S hospitals, according to the CDC’s National and State HAI Progress Report. Data compiled by around 38,000 institutions, including acute-care hospitals to long-term care facilities, paints an encouraging picture for 2023, indicating a reversal from trends seen during the COVID-19 pandemic.
Acute-care hospitals specifically report significant reductions in central line-associated bloodstream infections (CLABSIs), catheter-associated urinary tract infections (CAUTIs), and ventilator-associated events (VAEs) by 15%, 11%, and 5%, respectively. Other infections, including hospital-onset methicillin-resistant Staphylococcus aureus bacteremia and Clostridioides difficile infection (CDI), also decreased by 16% and 13%, respectively.
This positive development can be attributed in part to measures taken by local, state, and federal public health agencies. However, the battle against HAIs is far from over, with certain healthcare settings witnessing a surge in infection rates. Direct collaboration with healthcare partners and a rigorous commitment to HAI surveillance and preventive initiatives are paramount to maintaining and advancing this progress.
The fight against HAIs has been further bolstered by immunization practices, such as the routine vaccination of U.S adolescents with the quadrivalent meningococcal conjugate vaccine (MenACWY). A modeling study showed substantial reductions in invasive meningococcal disease (IMD) cases among adolescents and young adults aged 11 to 23.
The emphasis on surveillance and prevention of infectious diseases also extends to areas such as chronic wasting disease (CWD) in deer, with measures taken by the CDC and other global bodies to prevent human exposure. With rapid advancements in technology, researchers now use tools like FlowBEAT to explore correlations between disease-causing agents and the severity of illness, such as COVID-19. Unlocking these relationships can lead to better patient outcomes and guide further research.
Though progress is evident, sustained dedication to surveillance and prevention, along with harnessing technological advancements, remains central in the campaign against HAIs.